Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Operating Expenses | 1,493 | 4,887 | 1,174 | 795 | 1,098 |
| Operating Income | -1,493 | -4,887 | -1,174 | -795 | -1,098 |
| Interest Expense | 1 | N/A | N/A | N/A | N/A |
| Other Income | -82 | -16 | -73,315 | 121 | 88 |
| Pre-tax Income | -1,576 | -4,902 | -74,488 | -673 | -1,010 |
| Income Tax | -74 | 0 | 0 | 0 | 0 |
| Net Income Continuous | -1,502 | -4,902 | -74,488 | -673 | -1,010 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 190 |
| Net Income | $-1,502 | $-4,902 | $-74,488 | $-673 | $-820 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.14 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.14 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.14 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.14 | 0.00 | 0.00 |
| EBITDA(a) | $-1,569 | $-4,886 | $-1,174 | $-795 | $-1,098 |